Safety and Efficacy of a Novel Candidate Peptide Vaccine Against HCV Infection in Healthy Volunteers and in Treated (Non-responders/ Responders) Chronic HCV Patients. Clinical Trials Phases I and II
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Hepatitis C vaccine (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacodynamics
- 06 Dec 2012 New trial record
- 31 Oct 2012 Biomarkers information updated